How should the FDA regulate generative AI in medtech? Here are 5 takes

URL has been copied successfully!

Patients, providers and medtech firms submitted hundreds of comments to the Food and Drug Administration on how the agency should approach generative AI in medical devices.

Share this story:
Share by Email
X (Twitter)
Whatsapp
LinkedIn
Copy link

This post was originally published here.